A business-focused article previewing a major funding round for a preventive health startup and its plans for international expansion and data-driven diagnostics.
Key Takeaways
- Company raised $700 million in a Series C round valuing it at about $1.8 billion
- More than 100,000 scans have been completed across clinics in Sweden and the UK
- Funding will support US clinic launch, longitudinal dataset growth, and diagnostic technology development